New Jersey: Drug Company Donates Thousands to HIV/AIDS Organizations
May 16, 2013
Janssen Therapeutics, a division of New Brunswick, N.J.-based pharmaceutical company Johnson & Johnson, announced they will provide up to $30,000 in grants and/or charitable donations to 16 organizations, four of which are in the New York metropolitan area. The funding will increase awareness and provide treatment to HIV-positive individuals. Janssen will use their three-year-old pilot program, Linking in Need Communities to Care (LINCC), to make the donations. Through LINCC, Janssen has donated more than $1.6 million to service organizations across the nation since 2010.
New York Amsterdam News
05.06.2013; Glen Townes
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)